Biocompatibility reduces inflammation-induced apoptosis in mesothelial cells exposed to peritoneal dialysis fluid

Blood Purification
|March 14, 2015
PubMed
Abstract

Insights

Inflammation and high glucose degradation product (GDP) peritoneal dialysis (PD) fluids cause mesothelial cell death. This cell death is resistant to common apoptosis inhibitors, impacting PD treatment strategies.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biomaterials Science

Background:

  • Peritonitis is a serious complication of peritoneal dialysis (PD).
  • It leads to mesothelial cell death and peritoneal injury, potentially hindering PD.
  • The combined effects of inflammatory mediators and PD fluids on mesothelial cells are critical.

Purpose of the Study:

  • To investigate the synergistic impact of inflammatory mediators and PD fluids on mesothelial cell death.
  • To understand the mechanisms underlying PD-related peritonitis and cell injury.

Main Methods:

  • Utilized cultured human mesothelial cells.
  • Exposed cells to inflammatory cytokines (TNF-α, interferon-γ) and PD fluids with varying glucose degradation product (GDP) concentrations.

Main Results:

  • Inflammatory cytokines and high GDP PD fluids significantly increased mesothelial cell death compared to low GDP fluids or standard medium.
  • Cell death rates were significantly higher in high GDP PD fluid (25.88 ± 2.18%) than low GDP PD fluid (13.16 ± 3.29%) or RPMI (14.15 ± 1.68%).
  • Therapeutic approaches targeting BclxL, Apaf-1, or caspases did not prevent apoptosis induced by the combined inflammatory and PD fluid challenge.

Conclusions:

  • Inflammation and high GDP PD fluids synergistically promote mesothelial cell death.
  • This cell death pathway is resistant to several known therapeutic interventions.
  • Findings offer a basis for selecting appropriate PD fluids during peritonitis episodes.